New York Senate Bill 36: Permits prescription labels for mifepristone, misoprostol, and their generic alternatives to include the name of the prescribing health care practice instead of the name of the prescriber at the prescriber's request.

New York · 2025-2026 session

What it does

Permits prescription labels for mifepristone, misoprostol, and their generic alternatives to include the name of the prescribing health care practice instead of the name of the prescriber at the prescriber's request.

Latest action

APPROVAL MEMO.1 (2025-02-03)

See how S 36 affects you on CapitolKey

Browse more bills · CapitolKey home